Check out TBRC’s sale today for
The erythropoietin (EPO) market consists of sales of erythropoietin drugs by entities (organizations, sole traders, and partnerships) that manufacture erythropoietin biosimilars. Erythropoietin is a hormone produced by kidneys and plays a vital role in the production of red blood cells, which carry oxygen from the lungs to the rest of the body. Lack of sufficient erythropoietin results in low red blood cells, which may lead to anemia. EPO drugs are used for treatment for anemia, kidney disorders, cancer, and other conditions.
Global Erythropoietin (EPO) Market Size And Drivers:
The global erythropoietin market size is expected to grow from $0.96 billion in 2020 to $1.10 billion in 2021 at a compound annual growth rate (CAGR) of 14.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The EPO market is expected to reach $3.11 billion in 2025 at a CAGR of 30%. The rising incidence of chronic kidney diseases is anticipated to propel the demand for the erythropoietin market over the approaching years.
Request For A Sample For The Global Erythropoietin (EPO) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3436&type=smp
Trends In The Global Erythropoietin (EPO) Market
STADA Arzneimittel AG, a Germany-based pharmaceutical company, acquired majority stakes (51.34%) in Bioceuticals Arzneimittel AG for an undisclosed amount. The acquisition is expected to expand STADA Arzneimittel AG ‘s presence in the biosimilar sector. Bioceuticals Arzneimittel AG licenses marketing rights to Epoetin zeta and Epoetin biosimilar to STADA Arzneimittel AG. Bioceuticals Arzneimittel AG is a Germany-based company engaged in manufacturing and marketing active pharmaceutical ingredients including erythropoietin biosimilars.
Global Erythropoietin (EPO) Market Segments:
The global erythropoietin market is further segmented –
By Product: Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others
By Application: Cancer, Hematology, Renal Diseases, Neurology, Others
By Drug Class: Biologis, Biosimilar
By Geography: The global EPO market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Erythropoietin (EPO) Market At:
https://www.thebusinessresearchcompany.com/rEPOrt/erythropoietin-EPO-global-market-rEPOrt-2020-30-covid-19-growth-and-change
Erythropoietin (EPO) Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides erythropoietin (EPO) market overviews, analyzes and forecasts market size and growth for the global erythropoietin (EPO) market, erythropoietin (EPO) market share, erythropoietin (EPO) market players, erythropoietin (EPO) market segments and geographies, erythropoietin (EPO) market’s leading competitors’ revenues, profiles and market shares. The erythropoietin (EPO) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
